AMETEK’s (NYSE:AME) Q2 CY2026: Strong Sales
AMETEK (NYSE:AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year on year, exceeding Wall Street estimates by 4.4%, according to the company. Non-GAAP adjusted EPS was $2.09, up from $1.78 and 4.8% above consensus. Analysts expect full-year EPS of $8.46, up from $7.96.
How this was made
The 30-second read
Why it matters
Traders can use the reported beat versus Wall Street estimates, the margin expansion commentary, and the stated full-year EPS outlook (from $7.96 to $8.46, +6.3%) to reassess near-term valuation and earnings expectations.
Market read
A same-quarter earnings beat with margin expansion and a modestly positive full-year EPS trajectory can drive continued momentum in the stock, though the forward revenue growth outlook is described as decelerating.
What to watch
The piece emphasizes organic growth and acquisitions but does not quantify segment mix, backlog, or order trends, which are often key for sustaining the earnings trajectory.
Background
AMETEK is an electronic products manufacturer serving aerospace, power, and healthcare, and the article frames its Q2 performance against multi-year growth and margin trends.
Ticker impact
AMETEK reported Q2 CY2026 revenue of $2.04B (+15% YoY) and adjusted EPS of $2.09, both beating consensus, with shares up 3.2% to $251.50.
Near-term bias remains upward while traders digest the beat versus consensus and the implied earnings power.
The text provides specific Q2 results versus estimates and notes margin expansion and a slight full-year EPS guidance outperformance, but it does not include detailed forward guidance changes beyond consensus framing.
Market effects
Supports the industrials/electronic components growth narrative via evidence of organic growth and margin resilience.
No specific regional spillover beyond US-listed industrials sentiment.
No explicit global demand or macro linkage beyond general industrial demand headwinds.
Counterpoint
Despite the beat, the article flags decelerating growth (two-year annualized revenue growth below the five-year trend) and expects only 5.8% revenue growth over the next 12 months.
Key entities
- public_companyAMETEK
Reported Q2 CY2026 revenue and adjusted EPS beats, with commentary on organic growth, acquisitions, and margin expansion.
- executiveDavid A. Zapico
CEO/Chairman quoted on the drivers of Q2 performance, including organic sales growth and operating performance.
